Lithium carbonate
Lithium Carbonate is a prescription medication available as 300 mg extended-release tablets taken by mouth. It acts as a mood stabilizer to help manage certain mental health conditions like bipolar disorder. Manufactured by Rising Pharma Holdings, Inc. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Lithium Carbonate is a prescription medication available as 300 mg extended-release tablets taken by mouth. It acts as a mood stabilizer to help manage certain mental health conditions like bipolar disorder. Manufactured by Rising Pharma Holdings, Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Lithium carbonate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Lithium carbonate — ANDA 079139 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=079139"
}
]
|
| identifier | ANDA079139 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"fda",
"medications",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Lithium carbonate |
